Most Read Articles
04 Feb 2019
The carbon-chain length of saturated fatty acids appears to be an important factor in determining its role in cardiovascular health, a recent study has found.
6 days ago
Olanzapine confers a modest therapeutic effect on weight compared with placebo in adult outpatients with anorexia nervosa, a study has shown. However, it does not appear to offer significant benefit for psychological symptoms.
Pearl Toh, 3 days ago
A latest study at ISC 2019 shows that even patients with large-core stroke damage can have a good outcome after mechanical clot removal with endovascular thrombectomy (EVT), depending on the size of the infarct and time lapses between stroke onset and treatment.
Jairia Dela Cruz, 04 Feb 2019
Treatment with secukinumab results in a higher rate of remission or low-disease activity at week 16 in patients with psoriatic arthritis as compared with placebo, according to a posthoc analysis of the FUTURE 2 study. This effect is sustained at 2 years and is evident in both tumour necrosis factor inhibitor-experienced and -naïve patients.

Parental schizophrenia, depression tied to heightened risk of neurological disorders in offspring

06 Dec 2018

Children born to parents with schizophrenia are at increased risk of developing a variety of neurological disorders, as well as visual and hearing disorders, at an early age, a study has found. The same is true for those born to parents with a major depression.

The study included 7,107 children with a parent hospitalized for schizophrenia, 32,494 children with a parent hospitalized for major depression and 172,982 children with healthy parents. Researchers estimated the risk of childhood neurological disorder using Poisson regression.

Compared with children born to healthy parents, those born to parents with schizophrenia were more likely to have been hospitalized before the age of 10 years with a diagnosis of cerebral palsy (relative risk [RR], 1.76; 95 percent CI, 1.15–2.69), epilepsy (RR, 1.78; 1.33–2.40), combined neurological disease (RR, 1.33; 1.11–1.60), and certain diseases of the eye (RR, 1.92; 1.17–3.15) and ear (RR, 1.18; 1.05–1.32).

Similar results were obtained in children born to parents hospitalized with a diagnosis of major depression. In this group, an additional risk increase for strabismus was found (RR, 1.21; 1.05–1.40).

Compared with children to healthy parents, children to parents with schizophrenia have increased risk of a variety of neurological disorders as well as visual and hearing disorders at an early age. The risk increase was not specific to schizophrenia but was also seen in children to parents with a diagnosis of major depression.

Researchers cautioned that the study was based on the most severely ill patients and excluded those who may be more mildly affected by the disease. Therefore, the generalizability of the results may be limited to parents with a severe enough psychiatric condition to warrant hospitalization and, more importantly, severe enough eye, ear and neurological diseases so that the children required hospitalization at a young age.

Additional studies are needed to evaluate the risk in children with neurological diseases not requiring hospitalization, as well as a milder form of the eye and the ear conditions, to explore the connection between these diseases and schizophrenia further, they added.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
04 Feb 2019
The carbon-chain length of saturated fatty acids appears to be an important factor in determining its role in cardiovascular health, a recent study has found.
6 days ago
Olanzapine confers a modest therapeutic effect on weight compared with placebo in adult outpatients with anorexia nervosa, a study has shown. However, it does not appear to offer significant benefit for psychological symptoms.
Pearl Toh, 3 days ago
A latest study at ISC 2019 shows that even patients with large-core stroke damage can have a good outcome after mechanical clot removal with endovascular thrombectomy (EVT), depending on the size of the infarct and time lapses between stroke onset and treatment.
Jairia Dela Cruz, 04 Feb 2019
Treatment with secukinumab results in a higher rate of remission or low-disease activity at week 16 in patients with psoriatic arthritis as compared with placebo, according to a posthoc analysis of the FUTURE 2 study. This effect is sustained at 2 years and is evident in both tumour necrosis factor inhibitor-experienced and -naïve patients.